CURANUM AG

EANS-Adhoc: CURANUM AG
Subscription offer for capital increase completed successfully

--------------------------------------------------------------------------------
  ad-hoc disclosure pursuant to section 15 of the WpHG transmitted by euro
  adhoc with the aim of a Europe-wide distribution. The issuer is solely
  responsible for the content of this announcement.
--------------------------------------------------------------------------------
19.10.2012

Curanum AG has successfully completed the subscription offer for its capital
increase which was announced in the Federal Gazette on October 2, 2012. All new
shares were subscribed for.

In this context, demand for the new shares exceeded the offer by
more than two thirds significantly due to numerous oversubscription requests
submitted by
shareholders.

After Curanum AG has signed the follow-up financing agreement for the
borrower's note loan, the announcement of the implementation of the capital
increase will be entered in the commercial register.

Shareholders' oversubscription requests were taken into account in compliance
with the principle of equal treatment, and with the terms of the subscription
offer. Information about allocations will be published on Curanum's website at
www.curanum.de/Investor Relations/Capital Increase.

Munich, October 19, 2012

The Management Board


Further inquiry note:
Frau Caroline Lutz
Unternehmensentwicklung
Tel: 089/ 24 20 65-0
E-Mail: ir@curanum.de

end of announcement                               euro adhoc 
--------------------------------------------------------------------------------


issuer:      CURANUM AG
             Engelbertstraße 23-25
             D-81241 München
phone:       +49 (0)89 242065 0
FAX:         +49 (0) 89 242065 10
mail:     ir@curanum.de
WWW:      http://www.curanum.de
sector:      Healthcare Providers
ISIN:        DE0005240709
indexes:     CDAX, Classic All Share, Prime All Share
stockmarkets: free trade: Berlin, Hamburg, Düsseldorf, Stuttgart, regulated
             dealing: München, regulated dealing/prime standard: Frankfurt 
language:   English
 



Weitere Meldungen: CURANUM AG

Das könnte Sie auch interessieren: